Author

K. S. Wilcox

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3 Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:mouse· 4 Research Focus:drug response / drug discovery· 2 Assay:electrophysiology· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:rat· 1

Frequent Co-Authors

C. S. Metcalf· 3 shared C. Cornelssen· 2 shared C. D. Pernici· 2 shared E. J. Dahle· 2 shared J. A. Mensah· 2 shared K. J. Johnson· 2 shared P. J. West· 2 shared S. Senthilkumar· 2 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

C. S. Metcalf

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

A method for focused ultrasound (FUS) neuromodulation with simultaneous electroencephalogram recordings in awake, head-fixed mice with temporal lobe epilepsy

C. Cornelssen, B. Brown, E. Finlinson, S. Blair, S. Senthilkumar, J. Kubanek, K. S. Wilcox

This study develops a method to apply focused ultrasound neuromodulation in awake, head-fixed mice with temporal lobe epilepsy and evaluates its effects on seizure-like events.

bioRxiv · Mar 20, 2024 · PreprintBioengineering

Development of an MR-guided focused ultrasound (MRgFUS) lesioning approach for small and deep structures in the rat brain

C. Cornelssen, A. Payne, D. Parker, M. Alexander, R. Merrill, S. Senthilkumar, J. Christensen, K. S. Wilcox, H. Odeen, J. D. Rolston

This paper develops an MR-guided focused ultrasound lesioning method for small and deep brain structures in rats, achieving improved targeting accuracy.

bioRxiv · Oct 11, 2023 · PreprintBioengineering

Utilizing an acute hyperthermia-induced seizure test and pharmacokinetic studies to establish optimal dosing regimens in a mouse model of Dravet syndrome

J. A. Mensah, K. Johnson, T. Freeman, C. A. Reilly, J. E. Rower, C. S. Metcalf, K. S. Wilcox

This study evaluates combination therapies for Dravet Syndrome using a mouse model, finding that triple-drug regimens enhance seizure control through potential drug interactions.

bioRxiv · Oct 3, 2023Pharmacology & Toxicology

Evaluation of spontaneous seizure activity, sex-dependent differences, behavioral comorbidities, and alterations in CA1 neuron firing properties in a mouse model of Dravet Syndrome

C. D. Pernici, A. Spink, E. J. Dahle, K. J. Johnson, C. S. Metcalf, P. J. West, K. S. Wilcox

bioRxiv · Jun 16, 2021 · PreprintPharmacology & Toxicology

Development of an Antiseizure Drug Screening Platform for Dravet Syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program

C. D. Pernici, J. A. Mensah, E. J. Dahle, K. J. Johnson, L. J. Handy, L. L. Buxton, M. D. Smith, P. J. West, C. S. Metcalf, K. S. Wilcox

This paper evaluates a mouse model of Dravet syndrome for antiseizure drug screening, finding that it is highly refractory to common ASDs but responsive to specific treatments like clobazam and valproic acid.

bioRxiv · Dec 1, 2020Pharmacology & Toxicology